12-130876170-A-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_006325.5(RAN):c.*244A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00198 in 547,760 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0018 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 17 hom. )
Consequence
RAN
NM_006325.5 3_prime_UTR
NM_006325.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.16
Genes affected
RAN (HGNC:9846): (RAN, member RAS oncogene family) RAN (ras-related nuclear protein) is a small GTP binding protein belonging to the RAS superfamily that is essential for the translocation of RNA and proteins through the nuclear pore complex. The RAN protein is also involved in control of DNA synthesis and cell cycle progression. Nuclear localization of RAN requires the presence of regulator of chromosome condensation 1 (RCC1). Mutations in RAN disrupt DNA synthesis. Because of its many functions, it is likely that RAN interacts with several other proteins. RAN regulates formation and organization of the microtubule network independently of its role in the nucleus-cytosol exchange of macromolecules. RAN could be a key signaling molecule regulating microtubule polymerization during mitosis. RCC1 generates a high local concentration of RAN-GTP around chromatin which, in turn, induces the local nucleation of microtubules. RAN is an androgen receptor (AR) coactivator that binds differentially with different lengths of polyglutamine within the androgen receptor. Polyglutamine repeat expansion in the AR is linked to Kennedy's disease (X-linked spinal and bulbar muscular atrophy). RAN coactivation of the AR diminishes with polyglutamine expansion within the AR, and this weak coactivation may lead to partial androgen insensitivity during the development of Kennedy's disease. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00181 (276/152324) while in subpopulation EAS AF= 0.0423 (219/5178). AF 95% confidence interval is 0.0377. There are 6 homozygotes in gnomad4. There are 148 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 276 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAN | NM_006325.5 | c.*244A>G | 3_prime_UTR_variant | Exon 7 of 7 | ENST00000543796.6 | NP_006316.1 | ||
RAN | NM_001300796.2 | c.*244A>G | 3_prime_UTR_variant | Exon 6 of 6 | NP_001287725.1 | |||
RAN | NM_001300797.2 | c.*244A>G | 3_prime_UTR_variant | Exon 6 of 6 | NP_001287726.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAN | ENST00000543796.6 | c.*244A>G | 3_prime_UTR_variant | Exon 7 of 7 | 1 | NM_006325.5 | ENSP00000446215.1 | |||
RAN | ENST00000541679.7 | c.*291A>G | 3_prime_UTR_variant | Exon 4 of 4 | 5 | ENSP00000483687.1 |
Frequencies
GnomAD3 genomes AF: 0.00180 AC: 274AN: 152206Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
274
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00205 AC: 811AN: 395436Hom.: 17 Cov.: 2 AF XY: 0.00209 AC XY: 436AN XY: 208126
GnomAD4 exome
AF:
AC:
811
AN:
395436
Hom.:
Cov.:
2
AF XY:
AC XY:
436
AN XY:
208126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00181 AC: 276AN: 152324Hom.: 6 Cov.: 33 AF XY: 0.00199 AC XY: 148AN XY: 74496
GnomAD4 genome
AF:
AC:
276
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
148
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at